Dr. Vispute is currently a Research Scientist in the Toxicology department at Charles River Laboratories, Reno, NV. At Charles River, he serves as a Study Director and is responsible for design, conduct, interpretation, and reports of GLP and non-GLP preclinical toxicity studies of potential drug candidates in rodents and non-human primates. Dr. Vispute earned his PhD in Pharmacology from St. Johnís University, New York in December 2015. His graduate research focused on characterizing the regulation of Fibroblast growth factor (Fgf) 21 and its pathophysiological implications. He is a recipient of many graduate student awards for his scientific achievement. Dr. Vispute has a Bachelorís degree in Pharmacy from Mumbai University, India (2009) and is a registered Pharmacist in India. He has several publications in peer reviewed journals and has given presentations at international scientific meetings. In addition, Dr. Vispute volunteers as a reviewer for many peer-reviewed journals.
Dr. Vispute is interested in molecular and cellular toxicology, regulatory and safety evaluation of biopharmaceuticals, immunooncology, gene regulation, in vivo and in vitro pharmacology and toxicology.